Lida Qi

Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy

Joseph Grimsby, Ramakanth Sarabu, Wendy L. Corbett et al. · Science · 2003 · 531 citations

Glucose Affinity, Glycosylation, Medicine +15

Discovery of Piragliatin—First Glucokinase Activator Studied in Type 2 Diabetic Patients

Ramakanth Sarabu, Fred T. Bizzarro, Wendy L. Corbett et al. · Journal of Medicinal Chemistry · 2012 · 97 citations · Full text

Glycobiology, Metabolomic Profiling, Pathology +21

Facile Preparation of 3,7-Diazabicyclo[3.3.0]octane and 3,7,10-Triheterocyclic [3.3.3]Propellane Ring Systems from 1,5-Diazacyclooctane 3,7-Derivatives¹

P.R. Dave, Farhad Forohar, T. Axenrod et al. · The Journal of Organic Chemistry · 1996 · 50 citations

Unusual Transannular Cyclizations, Halogenation, Chemical Engineering +13

Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity

Kevin R. Guertin, L Setti, Lida Qi et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 47 citations · Full text

Biochemistry, Medicine, Natural Sciences +9

Discovery, Structure−Activity Relationships, Pharmacokinetics, and Efficacy of Glucokinase Activator (2<i>R</i>)-3-Cyclopentyl-2-(4-methanesulfonylphenyl)-<i>N</i>-thiazol-2-yl-propionamide (RO0281675)

Nancy-Ellen Haynes, Wendy L. Corbett, Fred T. Bizzarro et al. · Journal of Medicinal Chemistry · 2010 · 45 citations

Pharmaceutical Science, Glycobiology, Glucose Homeostasis +22